EV/EBITDA
-0.05
+0.01+16.67%
39 min ago
Summary:
Processa Pharmaceuticals EV/EBITDA is currently -0.05, with a rise of +0.01 (+16.67%) during the most recent trading day. Over the past year, it has increased by +0.77 (+93.90%). PCSA EV/EBITDA is now -111.11% below its all-time high of 0.45.PCSA EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
PCSA EV/EBITDA Performance
| PeriodPeriod | EV/EBITDAEV/EBITDA |
|---|---|
| todaytoday | +16.7% |
| 3 m3 months | -155.6% |
| 6 m6 months | -111.6% |
| ytdytd | +85.7% |
| 1 y1 year | +93.9% |
| 5 y5 years | +99.7% |
PCSA EV/EBITDA High & Low
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1 month | 0.00 | <-9999.0% | -0.07 | +28.6% |
| 3 m | 3 months | 0.12 | -141.7% | -0.07 | +28.6% |
| 6 m | 6 months | 0.45 | -111.1% | -0.14 | +64.3% |
| 1 y | 1 year | 0.45 | -111.1% | -0.95 | +94.7% |
| 3 y | 3 years | 0.45 | -111.1% | -5.88 | +99.2% |
| 5 y | 5 years | 0.45 | -111.1% | -33.47 | +99.8% |
| alltime | all time | 0.45 | -111.1% | -866.91 | +100.0% |
Processa Pharmaceuticals EV/EBITDA History
| Date | Value |
|---|---|
| 2024 | -0.05(-85.7%) |
| 2023 | -0.35(-39.7%) |
| 2022 | -0.58(-89.4%) |
| 2021 | -5.45(-0.5%) |
| 2020 | -5.48(-82.7%) |
| Date | Value |
|---|---|
| 2019 | -31.76(-10.6%) |
| 2018 | -35.52(-58.8%) |
| 2017 | -86.21(+81.6%) |
| 2016 | -47.47(+1972.9%) |
| 2015 | -2.29(-72.7%) |
| 2014 | -8.40 |
FAQ
- What is Processa Pharmaceuticals EV/EBITDA?
- What is the all time high EV/EBITDA for Processa Pharmaceuticals?
- What is PCSA EV/EBITDA year-to-date change?
- What is Processa Pharmaceuticals EV/EBITDA year-on-year change?
What is Processa Pharmaceuticals EV/EBITDA?
The current EV/EBITDA of PCSA is -0.05
What is the all time high EV/EBITDA for Processa Pharmaceuticals?
Processa Pharmaceuticals all-time high EV/EBITDA is 0.45
What is PCSA EV/EBITDA year-to-date change?
Processa Pharmaceuticals EV/EBITDA has changed by +0.30 (+85.71%) since the beginning of the year
What is Processa Pharmaceuticals EV/EBITDA year-on-year change?
Over the past year, PCSA EV/EBITDA has changed by +0.77 (+93.90%)